Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1-infected cells
- 30 June 1996
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 31 (1-2) , 69-77
- https://doi.org/10.1016/0166-3542(96)00946-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Hept Derivatives: 6-Benzyl-1-ethoxymethyl-5-isopropyluracil (MKC-442)Nucleosides, Nucleotides and Nucleic Acids, 1995
- Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strainsAntimicrobial Agents and Chemotherapy, 1995
- Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitroAntimicrobial Agents and Chemotherapy, 1994
- HIV resistance to reverse transcriptase inhibitorsBiochemical Pharmacology, 1994
- Knocking-Out Concentrations of HIV-1-Specific Inhibitors Completely Suppress HIV-1 Infection and Prevent the Emergence of Drug-Resistant VirusVirology, 1993
- Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitorsAntimicrobial Agents and Chemotherapy, 1993
- Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapyNature, 1993
- HIV-1-Specific Reverse Transcriptase Inhibitors Show Differential Activity against HIV-1 Mutant Strains Containing Different Amino Acid Substitutions in the Reverse TranscriptaseVirology, 1993
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989